Medicover AB (publ) (MCOV-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medicover AB (publ) (MCOV-B) has a cash flow conversion efficiency ratio of 0.170x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr980.72 Million ≈ $105.54 Million USD) by net assets (Skr5.76 Billion ≈ $619.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MCOV-B market cap for the company's overall valuation and market capitalisation.
Medicover AB (publ) - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Medicover AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medicover AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medicover AB (publ) ranked by their cash flow conversion efficiency. Explore MCOV-B cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Leili Motor Corp Ltd
SHE:300660
|
0.022x |
|
China Meheco Co Ltd
SHG:600056
|
0.016x |
|
Vimian Group AB
ST:VIMIAN
|
0.080x |
|
Partner
TA:PTNR
|
0.163x |
|
A10 Network
NYSE:ATEN
|
0.122x |
|
Gempharmatech Co. Ltd. A
SHG:688046
|
N/A |
|
Shenzhen Airport Co Ltd
SHE:000089
|
0.035x |
|
Sarepta Therapeutics Inc
NASDAQ:SRPT
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Medicover AB (publ) (2005–2024)
The table below shows the annual cash flow conversion efficiency of Medicover AB (publ) from 2005 to 2024. View Medicover AB (publ) (MCOV-B) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr489.30 Million ≈ $52.66 Million |
Skr261.90 Million ≈ $28.18 Million |
0.535x | +37.94% |
| 2023-12-31 | Skr528.30 Million ≈ $56.85 Million |
Skr205.00 Million ≈ $22.06 Million |
0.388x | +16.46% |
| 2022-12-31 | Skr510.80 Million ≈ $54.97 Million |
Skr170.20 Million ≈ $18.32 Million |
0.333x | -13.57% |
| 2021-12-31 | Skr562.10 Million ≈ $60.49 Million |
Skr216.70 Million ≈ $23.32 Million |
0.386x | +19.49% |
| 2020-12-31 | Skr483.50 Million ≈ $52.03 Million |
Skr156.00 Million ≈ $16.79 Million |
0.323x | +32.94% |
| 2019-12-31 | Skr359.70 Million ≈ $38.71 Million |
Skr87.30 Million ≈ $9.39 Million |
0.243x | +77.05% |
| 2018-12-31 | Skr323.90 Million ≈ $34.86 Million |
Skr44.40 Million ≈ $4.78 Million |
0.137x | -17.15% |
| 2017-12-31 | Skr304.00 Million ≈ $32.72 Million |
Skr50.30 Million ≈ $5.41 Million |
0.165x | -36.88% |
| 2016-12-31 | Skr98.80 Million ≈ $10.63 Million |
Skr25.90 Million ≈ $2.79 Million |
0.262x | -14.87% |
| 2015-12-31 | Skr93.20 Million ≈ $10.03 Million |
Skr28.70 Million ≈ $3.09 Million |
0.308x | +28.43% |
| 2014-12-31 | Skr90.50 Million ≈ $9.74 Million |
Skr21.70 Million ≈ $2.34 Million |
0.240x | +14.91% |
| 2005-12-31 | Skr23.55 Million ≈ $2.53 Million |
Skr4.91 Million ≈ $528.82K |
0.209x | -- |
About Medicover AB (publ)
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Servi… Read more